Showing results (101-110 of 552) with videos related to
Sort By:
Pageof 56
The Cancer Journal From Scientific American|February 24, 2000
High-dose recombinant interleukin-2 therapy in patients with metastatic melanoma: long-term survival updateM B Atkins, L Kunkel, M Sznol, et al.Pathology|August 1, 1996
Prevalence of Bartonella henselae bacteremia, the causative agent of cat scratch disease, in an Australian cat populationJ Branley, C Wolfson, P Waters, et al.Clinical Nurse Specialist CNS|March 1, 1996
Improving self-efficacy in nursing researchV E O'Halloran, S E Pollock, T Gottlieb, et al.Psychology Research and Behavior Management|May 22, 2015
A selective review of glutamate pharmacological therapy in obsessive-compulsive and related disordersMarco A Grados, Elizabeth B Atkins, Gabriela I Kovacikova, et al.Cytokine|October 1, 1995
Induction of circulating interleukin 10 by interleukin 1 and interleukin 2, but not interleukin 6 immunotherapyH Tilg, M B Atkins, C A Dinarello, et al.The New England Journal of Medicine|April 5, 1990
An acquired chemotactic defect in neutrophils from patients receiving interleukin-2 immunotherapyM S Klempner, R Noring, J W Mier, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 12, 2004
Standardization and quantification of radionuclide solid gastric-emptying studiesHarvey A Ziessman, Frederic H Fahey, Frank B Atkins, et al.Cancer Research|February 3, 2006
The Raf inhibitor BAY 43-9006 (Sorafenib) induces caspase-independent apoptosis in melanoma cellsDavid J Panka, Wei Wang, Michael B Atkins, et al.Cureus|May 26, 2026
Heat-Associated Mortality and Emergency Department Utilization in Southern Nevada During 2024: A Retrospective Descriptive AnalysisDeanna Chea, Justin B Atkins, Oscar A Toro Ruilowa, et al.Proceedings of the National Academy of Sciences of the United States of America|December 1, 1992
Leukotriene C4 uses a probenecid-sensitive export carrier that does not recognize leukotriene B4B K Lam, K Xu, M B Atkins, et al.Pageof 56